APA (7th ed.) Citation

E, A., F, K., G, B., & L, C. (2024). Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiology and drug safety, 33(6), e5814. https://doi.org/10.1002/pds.5814

Chicago Style (17th ed.) Citation

E, Ayme-Dietrich, Kaguelidou F, Bertschy G, and Chouchana L. "Use of Methylphenidate and Reporting of Valvular Heart Disease: Global Pharmacovigilance Analysis in Children and Adults." Pharmacoepidemiology and Drug Safety 33, no. 6 (2024): e5814. https://doi.org/10.1002/pds.5814.

MLA (9th ed.) Citation

E, Ayme-Dietrich, et al. "Use of Methylphenidate and Reporting of Valvular Heart Disease: Global Pharmacovigilance Analysis in Children and Adults." Pharmacoepidemiology and Drug Safety, vol. 33, no. 6, 2024, p. e5814, https://doi.org/10.1002/pds.5814.